HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability

被引:603
作者
Stopak, K
de Noronha, C
Yonemoto, W
Greene, WC [1 ]
机构
[1] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
关键词
D O I
10.1016/S1097-2765(03)00353-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human immunodeficiency virus type 1 (HIV-1) relies on Vif (viral infectivity factor) to overcome the potent antiviral function of APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G, also known as CEM15). Using an APOBEC3G-specific antiserum, we now show that Vif prevents virion incorporation of endogenous APOBEC3G by effectively depleting the intracellular levels of this enzyme in HIV-1-infected T cells. Vif achieves this depletion by both impairing the translation of APOBEC3G mRNA and accelerating the posttranslational degradation of the APOBEC3G protein by the 26S proteasome. Vif physically interacts with APOBEC3G, and expression of Vif alone in the absence of other HIV-1 proteins is sufficient to cause depletion of APOBEC3G. These findings highlight how the bimodal translational and posttranslational inhibitory effects of Vif on APOBEC3G combine to markedly suppress the expression of this potent antiviral enzyme in virally infected cells, thereby effectively curtailing the incorporation of APOBEC3G into newly formed HIV-1 virions.
引用
收藏
页码:591 / 601
页数:11
相关论文
共 30 条
[1]   GENERATION AND CHARACTERIZATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MUTANTS [J].
ADACHI, A ;
ONO, N ;
SAKAI, H ;
OGAWA, K ;
SHIBATA, R ;
KIYOMASU, T ;
MASUIKE, H ;
UEDA, S .
ARCHIVES OF VIROLOGY, 1991, 117 (1-2) :45-58
[2]   PROTEOLYSIS OF THE P220 COMPONENT OF THE CAP-BINDING PROTEIN COMPLEX IS NOT SUFFICIENT FOR COMPLETE INHIBITION OF HOST-CELL PROTEIN-SYNTHESIS AFTER POLIOVIRUS INFECTION [J].
BONNEAU, AM ;
SONENBERG, N .
JOURNAL OF VIROLOGY, 1987, 61 (04) :986-991
[3]   The predominant eIF4G-specific cleavage activity in poliovirus-infected HeLa cells is distinct from 2A protease [J].
Bovee, ML ;
Marissen, WE ;
Zamora, M ;
Lloyd, RE .
VIROLOGY, 1998, 245 (02) :229-240
[4]  
Boyer SN, 1996, CANCER RES, V56, P4620
[5]   A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor [J].
Bresnahan, PA ;
Yonemoto, W ;
Ferrell, S ;
Williams-Herman, D ;
Geleziunas, R ;
Greene, WC .
CURRENT BIOLOGY, 1998, 8 (22) :1235-1238
[6]  
CHATTON B, 1995, BIOTECHNIQUES, V18, P142
[7]   Identification of highly attenuated mutants of simian immunodeficiency virus [J].
Desrosiers, RC ;
Lifson, JD ;
Gibbs, JS ;
Czajak, SC ;
Howe, AYM ;
Arthur, LO ;
Johnson, RP .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1431-1437
[8]   Highly purified human immunodeficiency virus type 1 reveals a virtual absence of vif in virions [J].
Dettenhofer, M ;
Yu, XF .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1460-1467
[9]   The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation [J].
Didcock, L ;
Young, DF ;
Goodbourn, S ;
Randall, RE .
JOURNAL OF VIROLOGY, 1999, 73 (12) :9928-9933
[10]   HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells [J].
Eckstein, DA ;
Sherman, MP ;
Penn, ML ;
Chin, PS ;
De Noronha, CMC ;
Greene, WC ;
Goldsmith, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) :1407-1419